Weekly cisplatin (30-40 mg/m2) as radiosensitizer: Is it high or moderate emetic agent?
Karpe A, Patil VM, Joshi A, Noronha V, Gupta S, Ramaswamy A, Sahu A, Doshi V, Gupta T, Rath S, Banavali S, Prabhash K.
Karpe A, et al. Among authors: noronha v.
Indian J Cancer. 2016 Jul-Sep;53(3):454-456. doi: 10.4103/0019-509X.200666.
Indian J Cancer. 2016.
PMID: 28244483
Free article.